Early Tolerance and Tumor Control Outcomes with High-dose Ultrahypofractionated Radiation Therapy for Prostate Cancer-Reference-Cited by-同舟云学术

Early Tolerance and Tumor Control Outcomes with High-dose Ultrahypofractionated Radiation Therapy for Prostate Cancer

Published:2020-12 Issue:6 Volume:3 Page:748-755
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Zelefsky Michael J.,Pinitpatcharalert Attapol,Kollmeier Marisa,Goldman Debra A.,McBride Sean,Gorovets Daniel,Zhang Zhigang,Varghese Melissa,Happersett Laura,Tyagi Neelam,Hunt Margie

Funder

NIH/NCI Cancer Center

Publisher

Elsevier BV

Subject

Urology,Radiology Nuclear Medicine and imaging,Oncology,Surgery

Reference28 articles.

1. Stereotactic body radiotherapy for localized prostate cancer: pooled analysis from a multi-institutional consortium of prospective phase II trials;King;Radiother Oncol,2013

2. Long-term outcomes from a prospective trial of stereotactic body radiotherapy for low-risk prostate cancer;King;Int J Radiat Oncol Biol Phys,2012

3. Stereotactic body radiotherapy for low-risk prostate cancer: a 10-year analysis;Katz;Cureus,2017

4. Stereotactic body radiotherapy for prostate cancer;Henderson;Clin Oncol,2015

5. A phase II trial of stereotactic ablative body radiotherapy for low-risk prostate cancer using a non-robotic linear accelerator and real-time target tracking: report of toxicity, quality of life, and disease control outcomes with 5-year minimum follow-up;Mantz;Front Oncol,2014

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photon vs proton hypofractionation in prostate cancer: A systematic review and meta-analysis;Radiotherapy and Oncology;2024-06

2. Predictive value of magnetic resonance imaging diffusion parameters using artificial intelligence in low-and intermediate-risk prostate cancer patients treated with stereotactic ablative radiotherapy: A pilot study;Radiography;2024-05

3. Same-day versus delayed simulation imaging after placement of a perirectal hydrogel spacer for prostate radiotherapy;Frontiers in Oncology;2023-07-14

4. Quality Metric to Assess Adequacy of Hydrogel Rectal Spacer Placement for Prostate Radiation Therapy and Association of Metric Score With Rectal Toxicity Outcomes;Advances in Radiation Oncology;2023-07

5. Toxicity, quality of life, and PSA control after 50 Gy stereotactic body radiation therapy to the dominant intraprostatic nodule with the use of a rectal spacer: results of a phase I/II study;The British Journal of Radiology;2023-04-01